Identifying therapeutic candidates for Schizophrenia through HTS
This Poster summarizes a study from the London Centre for Therapeutics Discovery investigating allosteric modulators of the Dopamine D1 receptor, in order to identify potential therapeutic candidates for the treatment of Schizophrenia.
- Methodology followed by the authors
- Key results of the study (HTS performance and hit rates)
- Conclusion suggesting the identification of a novel allosteric modulator